PitchSend

Altria: CAGNY 2024

Agenda ● ● Capturing the growing harm reduction opportunity in the U.S.; Maintaining the strength of our highly profitable core tobacco businesses; Using our existing capabilities to expand beyond U.S. nicotine; and Continuing our commitment to create substantial value for shareholders. 4 | ALCS | CAGNY | 2.21.24 | For Investor Purposes ONLY Altria

View entire presentation